Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
25.4M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
-469K
-
Total reported value, excl. options
-
$4.15M
-
Value change
-
-$258K
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$0.38
Significant Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) as of Q1 2024
32 filings reported holding SNTI - Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 25.4M outstanding shares and own 43.33% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.43M shares), 8VC GP I, LLC (2.54M shares), ARK Investment Management LLC (1.63M shares), VANGUARD GROUP INC (707K shares), INTEL CORP (596K shares), Triatomic Management LP (311K shares), GEODE CAPITAL MANAGEMENT, LLC (246K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (145K shares), TWO SIGMA INVESTMENTS, LP (93.6K shares), and CITADEL ADVISORS LLC (79K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.